Director Shareholding

13 Jun 2005 12:59

ReGen Therapeutics PLC13 June 2005 13 June 2005 DIRECTOR SHAREHOLDING ReGen Therapeutics Plc (the "Company") announces that on 10 June 2005 itreceived notification from Dr P. Garrod, a non-executive director, that he hadacquired 1,000,000 ordinary shares of the Company at 1.25p per share. Dr Garrodnow holds and is beneficially interested in 38,750,000 ordinary sharesrepresenting 11.3% of the current issued share capital of the Company. For further information, please contact: Andrew MarshallMarshall Robinson RoeTel. 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange